Low-dose NOAC after COVID-19 hospitalization in patients with high thrombotic risk
This video was recorded in response to the presentation of the MICHELLE trial at the ESC congress
Prof. Verheugt - cardioloog in Amsterdam, The Netherlands.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.